October 20, 2025 - Health Technology Insights

October 20, 2025
HealthTech Media Room
AI in Healthcare, AI/ML, HealthTech News, News, news

Eleos Unveils Polaris AI Model for Post-Acute Care

Polaris AI leverages Google Cloud’s Gemini family of multimodal models and Eleos’ secure and clinically validated infrastructure to reduce documentation burden, strengthen compliance and help providers focus on care....

October 20, 2025
HealthTech Media Room
HealthTech News, News, news, Pharmaceuticals

Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions

Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced that it has successfully completed the acquisition of Prothya Biosolutions Belgium BV and its subsidiaries. This strategic move enhances Accord B.V.’s...

October 20, 2025
HealthTech Media Room
AI in Healthcare, AI/ML, HealthTech News, news, News

PointClickCare Launches New AI Solution and Rebrands Boldly

PointClickCare, a leading health tech company helping providers deliver exceptional care, announced the limited availability launch of its latest AI-powered innovation, Chart Advisor, alongside the unveiling of its refreshed...

October 20, 2025
HealthTech Media Room
HealthTech News, news, News, Women Health

51& Launches at HLTH to Boost Women’s Health Funding

At HLTH, healthcare’s #1 must-attend innovation event, 51&, a groundbreaking women’s health network, officially launched with a bold mission: to create sustainable, system-wide funding for women’s health through its pooled...

October 20, 2025
HealthTech Media Room
HealthTech News, News, news, Patient Experience

Oshi Health Launches Access+ to Boost GI Practice Growth

Oshi Health, the only nationwide virtual multidisciplinary gastrointestinal (GI) clinic, announced the launch of Access+ for GI practices, a new offering that enables local practices to overcome patient backlog, turn...

October 20, 2025
HealthTech Media Room
HealthTech News, News, news, Women Health

Elektra Health and Oscar Launch HelloMeno Menopause Plan

Elektra Health, a top virtual menopause care provider, and Oscar Health, Inc, a leading healthcare technology company, announced a groundbreaking partnership offering the first-ever menopause health plan, HelloMeno, in the ACA marketplace....

October 20, 2025
HealthTech Media Room
HealthTech News, Mental Health, News, news

Spring Health Launches VERA-MH for AI Validation in Mental Health

Developed in collaboration with a cross-disciplinary AI Council of technology, healthcare, and academic leaders, VERA-MH (Validation of Ethical and Responsible AI in Mental Health) is now open to the...

October 20, 2025
HealthTech Media Room
HealthTech News, news, News, Patient Experience

Ferring Shares New Real-World REBYOTA Data Boosting Patient Quality Of Life

Ferring Pharmaceuticals announced the presentation of two real-world data analyses for REBYOTA at IDWeek 2025. These analyses highlight the effectiveness and safety of REBYOTA in preventing recurrent Clostridioides difficile infection (rCDI) in...

October 20, 2025
HealthTech Media Room
Cancer, HealthTech News, News, news, Women Health

ENHERTU Plus THP Yields 67% Complete Response in HER2+ Breast Cancer

Positive results from the DESTINY-Breast11 phase 3 trial showed ENHERTU (trastuzumab deruxtecan) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting (before surgery) demonstrated a statistically significant and clinically meaningful...

October 20, 2025
HealthTech Media Room
HealthTech News, news, News

Trodelvy Cuts Disease Progression Risk by 38% in TNBC Trial

Gilead Sciences, Inc. shared positive data from the Phase 3 ASCENT-03 study demonstrating a highly statistically significant and clinically meaningful improvement in progression-free survival (PFS) for Trodelvy compared to...

October 20, 2025
HealthTech Staff Writer
Cancer, HealthTech News, News, news

XTANDI Plus Leuprolide Cuts Death Risk 40% in Prostate Cancer

Pfizer Inc. and Astellas Pharma U.S. Inc. revealed final overall survival results from the Phase 3 EMBARK trial studying XTANDI, in combination with leuprolide and as monotherapy, in men with non‑metastatic...

October 20, 2025
HealthTech Staff Writer
Cancer, HealthTech News, News, news

DS-3939 Shows Early Promise in Solid Tumor Trial

Daiichi Sankyo has announced encouraging early data from the dose escalation phase of its first-in-human Phase 1/2 trial of DS‑3939. The treatment showed promising clinical activity in patients with...